Entecavir trials for Hepatitis B

All Entecavir trials · All Hepatitis B trials

Phase breakdown

Recruiting trials studying Entecavir for Hepatitis B

• Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
  NCT07189377 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers
  NCT06966232 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
  NCT03933384 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF
  NCT03920618 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Entecavir for Hepatitis B?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.